Severe Edematous Facial Myositis Following Dual Influenza and COVID-19 Vaccination: A Case Report.

Publication date: Dec 01, 2024

Idiopathic inflammatory myopathies (IIM), or myositis, are a heterogeneous group of autoimmune disorders that can affect multiple organs, including the muscles, skin, joints, lungs, heart, and gastrointestinal tract. While new-onset myositis has been reported following SARS-CoV-2 infection, cases associated with COVID-19 vaccination remain rare. We describe a unique case of severe progressive edematous facial myositis resembling angioedema in a 22-year-old man, with onset one to two weeks after receiving dual SARS-CoV-2 and influenza vaccinations. This ultimately led to a diagnosis of systemic inflammatory myositis with extensive involvement of proximal muscles in the arms and legs. We outline the clinical course, diagnostic investigations, and treatments, and discuss the potential molecular mechanisms and existing literature on inflammatory myositis induced by SARS-CoV-2 infection or mRNA-based vaccination.

Open Access PDF

Concepts Keywords
Gastrointestinal covid-19 vaccine side-effects
Influenza facial angioedema
New immunosuppressant therapy
Old inflammatory myositis
Vaccinations mrna covid-19 vaccination

Semantics

Type Source Name
disease MESH Myositis
disease MESH Influenza
disease MESH COVID-19
pathway REACTOME SARS-CoV-2 Infection
disease MESH angioedema
disease MESH clinical course
pathway REACTOME Reproduction
disease MESH inflammation
disease MESH dermatomyositis
disease MESH antisynthetase syndrome
disease MESH myopathy
disease MESH etiology
disease MESH edema
disease IDO history
drug DRUGBANK Prednisone
disease MESH joint pain
disease MESH leukopenia
disease MESH thrombocytopenia
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Calcium
drug DRUGBANK Creatinine
drug DRUGBANK Alkaline Phosphatase
disease MESH proteinuria

Original Article

(Visited 1 times, 1 visits today)